CN103040554A
|
|
Surgical device for curing glaucoma by femtosecond laser transmitted by energy transmission optical fiber
|
CN102584943A
|
|
Vascular smooth muscle L type calcium ion channel immunogenic peptide and application thereof
|
CN103074375A
|
|
Inducible lentivirus miRNA expression vector and construction method thereof
|
CN102925356A
|
|
Cell culture insert
|
CN102260651A
|
|
Method for purifying virus-like particle protein and use thereof
|
CN102247604A
|
|
Angiotensin II receptor 1 type polypeptide-vector vaccine and application thereof
|
CN102337251A
|
|
Chimaera for HK97 bacteriophage virus-like particle and application of chimaera
|
CN102784400A
|
|
Brain tumor magnetic resonance contrast agent and its preparation method
|
CN102652836A
|
|
Targeting drug release anticancer protein or polypeptide polymer prodrug and preparation method thereof
|
CN102180950A
|
|
Human-derived voltage-gated potassium channel 1.3 immunogenic peptide fragment and application thereof
|
CN101897961A
|
|
Preparation method for B cell CD 22 extracellular inhibitive peptide fragment B2285 vaccines
|
CN102161754A
|
|
Functional modification method for branched polyethylene glycol (PEG) derivative
|
CN102160899A
|
|
Polyethylene glycol crosslinked decellularized valve multi-signal composite scaffold material and preparation method thereof
|
CN102144913A
|
|
Human balance detection and rehabilitation instrument
|
CN102144914A
|
|
Interference system for balanced sensation of human bodies
|
CN102119925A
|
|
Protein nano particle with tissue factor targeting property and preparation method and application thereof
|
CN101921733A
|
|
Preparation method and application of Qbeta-2aa phage virus-like particle protein
|
CN101701218A
|
|
Immune regulatory oligodeoxynucleotide for inhibiting differentiation of Th1 and Th17 and application thereof
|
CN101862230A
|
|
Controlled-release multilayer drug-loaded artificial bone and preparation method thereof
|
CN101768632A
|
|
Method for detecting aspergillus by polymerase chain reaction
|